Oral mucosal keratinocytes represent the cells that first encounter tobacco
components. Therefore, tobacco-induced abnormal alteration of the mucosal
keratinocytes may contribute to the development of oral white lesions. Nico
tine is an ingredient of all tobacco products and pharmacologically the mos
t active component of tobacco smoke. To clarify the effects of nicotine on
the keratinization of oral mucosal and epidermal keratinocytes, we reconstr
ucted artificial buccal mucosal and skin equivalents using keratinocytes an
d fibroblasts from noncornifying buccal mucosa and adult foreskin, respecti
vely. The effect of nicotine on keratinization was assessed with morphology
, immunohistochemistry and immunoblotting. Long-term treatment with nicotin
e for 2 weeks enhanced in a dose-dependent manner the expression of differe
ntiation-specific proteins of oral mucosal keratinocytes on living oral muc
osal equivalent and epidermal keratinocytes on living skin equivalent, resp
ectively. The effect of nicotine on the cell viability was measured by the
3-(4,5-dimethylthiazol-2-yl)-2,5-diphenyl tetrazolium bromide assay. Oral m
ucosal keratinocytes showed a higher resistance to nicotine toxicity than e
pidermal keratinocytes. Our results suggest that nicotine stimulates differ
entiation of both mucosal and epidermal keratinocytes, and this nicotine-in
duced abnormal differentiation may be associated with the development of or
al white lesions.